BLUEJET vs INDOCO: Stock Comparison

Blue Jet Healthcare Limited vs Indoco Remedies Limited

Live data: 22 July 2026, 2:52 PM IST • Source: NSE and company filings

Blue Jet Healthcare Limited is the larger company by market capitalisation. Blue Jet Healthcare Limited shows a higher ROE, a higher dividend yield and lower leverage, while Indoco Remedies Limited shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Blue Jet Healthcare Limited and Indoco Remedies Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLUEJET is more favourable on 7 of 11 scored metrics and INDOCO on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BLUEJET is the larger company
₹10,169 Cr vs ₹2,160 Cr
P/E Ratio
INDOCO has a lower P/E
-23.83x vs 41.21x
P/B Ratio
INDOCO has a lower P/B
2.41x vs 7.51x
EPS
BLUEJET has higher earnings per share
₹14.27 vs ₹-10.71
Dividend Yield
BLUEJET has a higher dividend yield
0.2% vs 0.08%
Revenue Growth (TTM YoY)
INDOCO has faster revenue growth
21.9% vs -31.1%
EPS Growth (TTM YoY)
INDOCO has faster EPS growth
0% vs -41.5%
ROE
BLUEJET has a higher ROE
52.1% vs -9.42%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLUEJETINDOCO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLUEJETINDOCO
Live Price₹584.95₹233.99
Day Change-0.77%-4.82%
Volume5.46 L71,688
52-Week High₹1,022₹336
52-Week Low₹325₹162.19
Distance from 52W High-42.76%-30.36%

Valuation

MetricBLUEJETINDOCO
Market Cap₹10,169 Cr₹2,160 Cr
P/E Ratio41.21x-23.83x
P/B Ratio7.51x2.41x
EPS₹14.27₹-10.71
Book Value₹78.41₹111.55
Dividend Yield0.2%0.08%

Growth

MetricBLUEJETINDOCO
Revenue Growth (TTM YoY)-31.1%21.9%
EPS Growth (TTM YoY)-41.5%0%
Qtr Sales Growth21.9%
Qtr Profit Growth39%

Profitability & Leverage

MetricBLUEJETINDOCO
ROE52.1%-9.42%
ROCE57.3%0.93%
Net Margin27.25%-5.31%
Operating Margin41.3%7.68%
Debt to Equity0.16x1.16x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLUEJETINDOCO
Promoter Holding79.81%58.86%
FII Holding0.4% 0.48 pp1.27% 0.33 pp
DII Holding4.65% 0.14 pp17.68% 0.47 pp
Public Holding15.14% 0.34 pp22.04% 0.14 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Blue Jet Healthcare Limited and Indoco Remedies Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.